Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Home-based transcranial photobiomodulation improves cognitive function in mild cognitive impairment due to Alzheimer's disease: A randomized, double-blind, placebo-controlled confirmatory trial

The observed benefits are consistent with enhanced mitochondrial metabolism, cerebral perfusion, and synaptic efficiency.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a randomized, double-blind, placebo-controlled trial of home-administered transcranial photobiomodulation in 80 people with mild cognitive impairment due to Alzheimer's disease over 12 weeks. Active treatment was associated with greater improvement on the MoCA-K score than placebo, with no device-related adverse events reported.

Participants
80
Who or what was studied
Adults with mild cognitive impairment due to Alzheimer's disease meeting NIA-AA criteria
Wavelengths
808 nm
Limits stated in the abstract
The abstract does not report a sample size per group or long-term follow-up, and the authors' mechanistic explanations are interpretive rather than directly measured.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
808 nm

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Transcranial photobiomodulation, Mild cognitive impairment, Photobiomodulation, Placebo-controlled, Montreal Cognitive Assessment, Near-infrared, Neuromodulation, Primary outcome. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Brain & Neurology

A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial

Cognitive, metabolic, and network-level findings are consistent with enhanced mitochondrial efficiency and anti-inflammatory effects. These results support larger, double-blind, multicenter trials to evaluate tPBM as a mitochondria-targeted therapy in early ADRD.

Trial · June 3, 2026 · Rashidi-Ranjbar N et al.